Unlocking Success: Strategies for Preventing and Managing Complications in Chronic Total Occlusion Percutaneous

Reza Masoomi1, Kathleen E Kearney1, Rhian E Davies2

  • 1Division of Cardiology, University of Washington, Seattle, Washington.

PubMed

Insights

Managing complications in percutaneous coronary intervention (PCI), especially for chronic total occlusion (CTO) cases, requires a focus on prevention and preparedness. Learning from complications enhances patient safety and advances CTO PCI practices.

Area of Science:

  • Interventional Cardiology
  • Cardiovascular Surgery

Background:

  • Percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) presents significant challenges.
  • Complications during CTO PCI, such as perforation and tamponade, contribute to a 0.4% in-hospital mortality rate.

Purpose of the Study:

  • To outline a framework for managing complications in CTO PCI.
  • To emphasize prevention, preparedness, and learning from adverse events.

Main Methods:

  • Adherence to the "3 Ps" framework: prevention, preparedness, and planning.
  • Ensuring comprehensive patient discussions and adherence to appropriateness use criteria.
  • Maintaining a well-trained team with standardized equipment.

Main Results:

  • Identified specific CTO PCI complications including donor vessel injury, equipment loss/entrapment, radiation injury, and coronary perforation.
  • Highlighted the importance of risk assessment tools for evaluating periprocedural risks.
  • Stressed the value of extracting insights from complications for continuous improvement.

Conclusions:

  • A proactive approach focusing on prevention and preparedness is crucial for managing CTO PCI complications.
  • Continuous learning from complications is vital for advancing CTO PCI practices and improving patient outcomes.
  • Effective management involves patient communication, team training, and standardized protocols.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...